.jpg)
.png)
2018 NLA Nominating Committee Posts Report
The 2018 National Lipid Association Nominating Committee released its annual report and recommendations on Thursday.
This page was last updated: Jun 25, 2019
Several genetic lipid disorders manifest with physical examination findings in the palms, making it important for lipid specialists to examine the palms of each patient.
Article By:
ZAHID AHMAD, MD
Assistant Professor
Division of Nutrition and Metabolic Disease
Department of Internal Medicine
UT Southwestern Medical Center
Dallas, TX
ABHIMANYU GARG, MD
Professor
Division of Nutrition and Metabolic Disease
Department of Internal Medicine
UT Southwestern Medical Center
Dallas, TX
Several genetic lipid disorders manifest with physical examination findings in the palms, making it important for lipid specialists to examine the palms of each patient.
Article By:
ZAHID AHMAD, MD
Assistant Professor
Division of Nutrition and Metabolic Disease
Department of Internal Medicine
UT Southwestern Medical Center
Dallas, TX
ABHIMANYU GARG, MD
Professor
Division of Nutrition and Metabolic Disease
Department of Internal Medicine
UT Southwestern Medical Center
Dallas, TX
A 47-year-old, non-smoking man with a history of type 2 diabetes mellitus, elevated lipoprotein(a) [Lp(a)] level, and a family history significant for dyslipidemia and premature coronary artery disease (CAD) presents to clinic for routine medical appointment.
Article By:
JANE WANG, BS
Johns Hopkins University School of Medicine
Baltimore, MD
SETH S. MARTIN, MD, MHS
Johns Hopkins University School of Medicine
Baltimore, MD
When I entered medical school at the University of Washington in Seattle quite a few years ago, I soon came to the realization that cardiovascular disease was one of my primary areas of academic interest.
Article By:
KAYE-EILEEN WILLARD, MD, FNLA
Medical Director Lipid Clinic and Physician Advisor for Chronic Disease Management Ascension
Wisconsin All Saints
Racine, WI
Welcome to another Potpourri issue of LipidSpin. As you can see for yourself, this issue is a “grab-bag” of different lipid topics from clinicians, researchers, active NLA members and rising leaders.
Article By:
DANIEL E. SOFFER, MD, FACP, FNLA
Clinical Associate Professor of Medicine
University of Pennsylvania Internal Medicine and Preventive Cardiology
University of Pennsylvania Health System
Philadelphia, PA Diplomate
It really is fascinating how fast time flies because it seems like just yesterday I was taking the reins from Joyce Ross, MSN, CRNP, FNLA and beginning my term as National Lipid Association President. And here I am now about to wish Alan Brown, MD, FNLA the very best as he begins his term.
Article By:
JAMES A. UNDERBERG, MD, MS, FNLA
President, National Lipid Association
Clinical Assistant Professor of Medicine
NYU School of Medicine & NYU Center for
Prevention of Cardiovascular Disease
Director, Bellevue Hospital Lipid Clinic New York, NY
Diplomate, American Board of Clinical Lipidology
Last Updated: Monday, 30-Apr-2018 19:00:00 EDT
Chicago-area cardiologist assumes role during NLA Scientific Sessions in Las Vegas
Last Updated: Saturday, 10-Mar-2018 21:15:00 EST
ORLANDO (March 10, 2018) – The ODYSSEY OUTCOMES trial results, announced today at the American College of Cardiology 67th Annual Scientific Sessions in Orlando, revealed the addition of alirocumab to maximally tolerated statin significantly reduced major adverse cardiovascular events (MACE) compared to those on maximally tolerated statin and placebo.
The Foundation continues to be thankful for another successful year in 2017. As the President of the Foundation of the National Lipid Association (NLA), I want to thank each and every one of you who made a contribution and supported our great Association. Last year was a big year for the Foundation. We updated our mission and vision statements, designed and launched a brand-new website (www.
Article By:
ANNE C. GOLDBERG, MD, FNLA
President, Foundation of the National Lipid Association
Associate Professor of Medicine
Washington University School of Medicine
St. Louis, MO
Diplomate, American Board of Clinical Lipidology